Absolute immunoquantification of the expression of ABC transporters P-glycoprotein, breast cancer resistance protein and multidrug resistance-associated protein 2 in human liver and duodenum

被引:62
|
作者
Tucker, Theodora G. H. A. [1 ]
Milne, Alison M. [1 ]
Fournel-Gigleux, Sylvie [1 ,2 ]
Fenner, Katherine S. [3 ]
Coughtrie, Michael W. H. [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Dundee DD1 9SY, Scotland
[2] Univ Nancy 1, CNRS, UMR 7561, F-54505 Vandoeuvre Les Nancy, France
[3] Pfizer Global Res & Dev, Drug Metab Pharmacokinet & Dynam, Sandwich, Kent, England
基金
英国生物技术与生命科学研究理事会;
关键词
Drug transporters; Immunoquantification; BCRP; MRP2; P-glycoprotein; DRUG TRANSPORTERS; EXPORT PUMP; QUANTIFICATION; MRP2; GENE; SULFOTRANSFERASE; LOCALIZATION; MRP2/ABCC2; BCRP/ABCG2; INTESTINE;
D O I
10.1016/j.bcp.2011.10.017
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The ATP-binding cassette (ABC) transporters breast cancer resistance protein (BCRP), multidrug resistance-associated protein 2 (MRP2), and P-glycoprotein (Pgp) are important in the distribution and elimination of many drugs and endogenous metabolites. Due to their membrane location and hydrophobicity it is difficult to generate purified protein standards to quantify these transporters in human tissues. The present study generated transporter proteins fused with the S-peptide of ribonuclease for use as standards in immunoquantification in human liver and small intestine. Quantification of the S.tag (TM), a 15 amino acid peptide, is based on the formation of a functional ribonuclease activity upon its high affinity reconstitution with ribonuclease S-protein. S-tagged transporters were used as full-length protein standards in the immunoquantification of endogenous BCRP, MRP2, and Pgp levels in 14 duodenum and 13 liver human tissue samples. Expression levels in the duodenum were 305 +/- 248 (BCRP), 66 +/- 70 (MRP2), and 275 +/- 205 (Pgp) fmoles per cm(2). Hepatic levels were 2.6 +/- 0.9 (BCRP), 19.8 +/- 10.5 (MRP2), and 26.1 +/- 10.1 (total Pgp) pmoles per g of liver. The mean hepatic scaling factor was 35.8 mg crude membrane per g of liver, and the mean duodenal scaling factor was 1.3 mg crude membrane per cm(2) mucosal lining. Interindividual variability was greater in duodenal samples than liver samples. It is hoped that this innovative method of quantifying these transporters (and other membrane proteins) will improve in vivo-in vitro extrapolation and in silica prediction of drug absorption and elimination, thus supporting drug development. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:279 / 285
页数:7
相关论文
共 50 条
  • [1] Expression of P-glycoprotein and Multidrug Resistance-associated Protein is Associated with Multidrug Resistance in Gastric Cancer
    Xu, H-W
    Xu, L.
    Hao, J-H
    Qin, C-Y
    Liu, H.
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2010, 38 (01) : 34 - 42
  • [2] The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer
    Wen-Qing Hu
    Chun-Wei Peng
    Yan Li
    [J]. Journal of Experimental & Clinical Cancer Research, 28
  • [3] The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer
    Hu, Wen-Qing
    Peng, Chun-Wei
    Li, Yan
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2009, 28
  • [4] Histopathological assessment of multidrug resistance in gastric cancer: Expression of P-glycoprotein, multidrug resistance-associated protein, and lung-resistance protein
    Delamou Alexander
    Tetsu Yamamoto
    Shizuo Kato
    Shinichi Kasai
    [J]. Surgery Today, 1999, 29 : 401 - 406
  • [5] Histopathological assessment of multidrug resistance in gastric cancer: Expression of P-glycoprotein, multidrug resistance-associated protein, and lung-resistance protein
    Alexander, D
    Yamamoto, T
    Kato, S
    Kasai, S
    [J]. SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1999, 29 (05): : 401 - 406
  • [6] Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity
    Deng, Feng
    Ghemtio, Leo
    Grazhdankin, Evgeni
    Wipf, Peter
    Xhaard, Henri
    Kidron, Heidi
    [J]. MOLECULAR PHARMACEUTICS, 2020, 17 (07) : 2398 - 2410
  • [7] Effect of acetaminophen on expression and activity of rat liver multidrug resistance-associated protein 2 and P-glycoprotein
    Ghanem, CI
    Gómez, PC
    Arana, MC
    Perassolo, M
    Ruiz, ML
    Villanueva, SSM
    Ochoa, EJ
    Catania, VA
    Bengochea, LA
    Mottino, AD
    [J]. BIOCHEMICAL PHARMACOLOGY, 2004, 68 (04) : 791 - 798
  • [8] Interactions of retinoids with the ABC transporters P-glycoprotein and Breast Cancer Resistance Protein
    Tarapcsak, Szabolcs
    Szaloki, Gabor
    Telbisz, Agnes
    Gyoengy, Zsuzsanna
    Matuz, Krisztina
    Csosz, Eva
    Nagy, Peter
    Holb, Imre J.
    Ruehl, Ralph
    Nagy, Laszlo
    Szabo, Gabor
    Goda, Katalin
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [9] Interactions of retinoids with the ABC transporters P-glycoprotein and Breast Cancer Resistance Protein
    Szabolcs Tarapcsák
    Gábor Szalóki
    Ágnes Telbisz
    Zsuzsanna Gyöngy
    Krisztina Matúz
    Éva Csősz
    Péter Nagy
    Imre J. Holb
    Ralph Rühl
    László Nagy
    Gábor Szabó
    Katalin Goda
    [J]. Scientific Reports, 7
  • [10] Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma
    Arts, HJG
    Katsaros, D
    de Vries, EGE
    Massobrio, M
    Genta, F
    Danese, S
    Arisio, R
    Scheper, RJ
    Kool, M
    Scheffer, GL
    Willemse, PHB
    van der Zee, AGJ
    Suurmeijer, AJH
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 (10) : 2798 - 2805